Thymidine phosphorylase (TP) activation: Convenience through innovation

Oncologist

Volumn 6, Issue SUPPL. 4, 2001, Pages 1-2

  Van Cutsem, Eric ^a   Cunningham, David ^b,c   Hoff, Paulo M ^d   Maroun, Jean ^e  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; THYMIDINE PHOSPHORYLASE;

ANTINEOPLASTIC ACTIVITY; COLORECTAL CANCER; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG TOLERABILITY; ENZYME ACTIVATION; PRIORITY JOURNAL;

EID: 0034796469     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.6-suppl_4-1     Document Type: Conference Paper

References (15)

1. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
2. Infusional 5-fluorouracil can be a pain in the neck: A case for repositioning displaced Hickman lines
3. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
4. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
5. Capecitabine as first-line treatment for colorectal cancer (CRC): Integrated results of 1207 patients (pts) from 2 randomized, phase III studies
6. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
7. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
8. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
9. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
10. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
11. Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
12. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
13. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
14. Capecitabine combined with simultaneous radiotherapy in rectal cancer: A phase-I-study
15. Incorporating oral capecitabine into the treatment of colorectal cancer